These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5911531)

  • 1. Dealkylation studies on inhibited acetylcholinesterase.
    Coult DB; Marsh DJ; Read G
    Biochem J; 1966 Mar; 98(3):869-73. PubMed ID: 5911531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the affinity and phosphorylation constants governing irreversible inhibition of cholinesterases by di-isopropyl phosphorofluoridate.
    Main AR; Iverson F
    Biochem J; 1966 Aug; 100(2):525-31. PubMed ID: 5968549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dealkylation as a mechanism for aging of cholinesterase after poisoning with pinacolyl methylphosphonofluoridate.
    Fleisher JH; Harris LW
    Biochem Pharmacol; 1965 May; 14(5):641-50. PubMed ID: 5840724
    [No Abstract]   [Full Text] [Related]  

  • 4. A radiometric study of cholinesterase and its inhibition.
    Winteringham FP; Disney RW
    Biochem J; 1964 Jun; 91(3):506-14. PubMed ID: 5840710
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxamic acids: relationship between structure and ability to reactivate phosphonate-inhibited acetylcholinesterase.
    GILBERT G; WAGNER-JAUREGG T; STEINBERG GM
    Arch Biochem Biophys; 1961 Jun; 93():469-75. PubMed ID: 13705238
    [No Abstract]   [Full Text] [Related]  

  • 6. Formation of nonreactivatible isopropylmethylphosphonofluoridate-inhibited acetylcholinesterase.
    Smith TE; Usdin E
    Biochemistry; 1966 Sep; 5(9):2914-8. PubMed ID: 5961880
    [No Abstract]   [Full Text] [Related]  

  • 7. The number of catalytic sites in acetylcholinesterase.
    Leuzinger W
    Biochem J; 1971 Jun; 123(2):139-41. PubMed ID: 5127329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dephosphorylation in vivo of brain acetylcholinesterase inhibited by isopropyl methylphosphonofluoridate (Sarin).
    Fleisher JH; Harris LW; Berkowitz PT
    Biochem Pharmacol; 1970 Feb; 19(2):421-6. PubMed ID: 5507658
    [No Abstract]   [Full Text] [Related]  

  • 9. The reaction of acetylcholinesterase with phosphylated oximes.
    Rogne O
    Biochem Pharmacol; 1967 Oct; 16(10):1853-8. PubMed ID: 6065954
    [No Abstract]   [Full Text] [Related]  

  • 10. De novo synthesis of acetylcholinesterase in guinea pig retina after inhibition by pinacolyl methylphosphonofluoridate.
    Harris LW; Yamamura HI; Fleisher JH
    Biochem Pharmacol; 1971 Oct; 20(10):2927-30. PubMed ID: 5114524
    [No Abstract]   [Full Text] [Related]  

  • 11. Aging of mipafox-inhibited human acetylcholinesterase proceeds by displacement of both isopropylamine groups to yield a phosphate adduct.
    Kropp TJ; Richardson RJ
    Chem Res Toxicol; 2006 Feb; 19(2):334-9. PubMed ID: 16485911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid aging of neurotoxic esterase after inhibition by di-isopropyl phosphorofluoridate.
    Clothier B; Johnson MK
    Biochem J; 1979 Feb; 177(2):549-58. PubMed ID: 435251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct determination of the chemical composition of acetylcholinesterase phosphonylation products utilizing electrospray-ionization mass spectrometry.
    Barak R; Ordentlich A; Barak D; Fischer M; Benschop HP; De Jong LP; Segall Y; Velan B; Shafferman A
    FEBS Lett; 1997 May; 407(3):347-52. PubMed ID: 9175882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A covalent affinity column for the purification of acetylcholinesterase.
    Ashani Y; Wilson IB
    Biochim Biophys Acta; 1972 Jul; 276(1):317-22. PubMed ID: 5047710
    [No Abstract]   [Full Text] [Related]  

  • 15. The administration of di-isopropyl fluorophosphate (DFP) to man; effect on plasma and erythrocyte cholinesterase; general systemic effects; use in study of hepatic function and erythropoiesis; and some properties of plasma cholinesterase.
    GROB D; LILIENTHAL JL
    Bull Johns Hopkins Hosp; 1947 Oct; 81(4):217-44. PubMed ID: 20340580
    [No Abstract]   [Full Text] [Related]  

  • 16. Sterospecificity of hydrolytic enzymes in their reaction with optically active organophosphorus compounds. I. The reaction of cholinesterases and paraoxonase with S-alkyl P-nitrophenyl methylphosphonothiolates.
    Oooms AJ; Boter HL
    Biochem Pharmacol; 1965 Dec; 14(12):1839-45. PubMed ID: 4286530
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydrophobic bonding of trialkyl phosphates and phosphorothiolates to acetylcholinesterase.
    Bracha P; O'Brien RD
    Biochemistry; 1970 Feb; 9(4):741-5. PubMed ID: 5417394
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorescent phosphonate label for serine hydrolases, pyrenebutyl methylphosphonofluoridate: reaction with acetylcholinesterase.
    Berman HA; Taylor P
    Biochemistry; 1978 May; 17(9):1704-13. PubMed ID: 566114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Kinetic studies on the protection, by alkane-bis-ammonium and alkane-bis-amino compounds, of acetylcholinesterase against diisopropylfluorophosphate poisoning].
    Ohnesorge FK; Tonner HD
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):290. PubMed ID: 4242432
    [No Abstract]   [Full Text] [Related]  

  • 20. The reaction of organophosphorus compounds with hydrolytic enzymes. II. The inhibition of citrus acetylesterase.
    Ooms AJ; Breebaart-Hansen JC; Ceulen BI
    Biochem Pharmacol; 1966 Jan; 15(1):17-30. PubMed ID: 5939082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.